Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3ha8 | 5JZ | Mitogen-activated protein kinase 14 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
3ha8 | 5JZ | Mitogen-activated protein kinase 14 | / | 1.000 | |
3fmn | 530 | Mitogen-activated protein kinase 14 | / | 0.585 | |
1bl6 | SB6 | Mitogen-activated protein kinase 14 | / | 0.580 | |
3hp5 | 52P | Mitogen-activated protein kinase 14 | / | 0.580 | |
3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.568 | |
3fly | FLY | Mitogen-activated protein kinase 14 | / | 0.567 | |
3fl4 | FL4 | Mitogen-activated protein kinase 14 | / | 0.566 | |
1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.565 | |
2zb0 | GK3 | Mitogen-activated protein kinase 14 | / | 0.562 | |
3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.562 | |
1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.561 | |
3fsk | RO6 | Mitogen-activated protein kinase 14 | / | 0.556 | |
3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.555 | |
3gfe | P37 | Mitogen-activated protein kinase 14 | / | 0.555 | |
3zsh | 469 | Mitogen-activated protein kinase 14 | / | 0.554 | |
3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.552 | |
3fml | FML | Mitogen-activated protein kinase 14 | / | 0.552 | |
3flw | FLW | Mitogen-activated protein kinase 14 | / | 0.548 | |
1ouk | 084 | Mitogen-activated protein kinase 14 | / | 0.545 | |
3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.545 | |
4eh5 | 0OM | Mitogen-activated protein kinase 14 | / | 0.545 | |
1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.544 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.544 | |
1w84 | L12 | Mitogen-activated protein kinase 14 | / | 0.543 | |
1m7q | DQO | Mitogen-activated protein kinase 14 | / | 0.542 | |
3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.542 | |
3iph | G11 | Mitogen-activated protein kinase 14 | / | 0.540 | |
1zzl | TZY | Mitogen-activated protein kinase 14 | / | 0.538 | |
3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.538 | |
3fmm | XI2 | Mitogen-activated protein kinase 14 | / | 0.535 | |
3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.535 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.535 | |
3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.533 | |
3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.529 | |
3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.528 | |
3hll | I45 | Mitogen-activated protein kinase 14 | / | 0.527 | |
3itz | P66 | Mitogen-activated protein kinase 14 | / | 0.527 | |
3gc7 | B45 | Mitogen-activated protein kinase 14 | / | 0.525 | |
3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.525 | |
3fc1 | 52P | Mitogen-activated protein kinase 14 | / | 0.524 | |
3fkn | FKN | Mitogen-activated protein kinase 14 | / | 0.524 | |
1yqj | 6NP | Mitogen-activated protein kinase 14 | / | 0.523 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.519 | |
1ove | 358 | Mitogen-activated protein kinase 14 | / | 0.518 | |
2qd9 | LGF | Mitogen-activated protein kinase 14 | / | 0.518 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.518 | |
3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.517 | |
3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.512 | |
2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.511 | |
4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.509 | |
3uib | SB2 | Putative mitogen-activated protein kinase | / | 0.507 | |
3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.505 | |
3o8t | BMU | Mitogen-activated protein kinase 14 | / | 0.505 | |
2zaz | GK1 | Mitogen-activated protein kinase 14 | / | 0.504 | |
3l8s | BFF | Mitogen-activated protein kinase 14 | / | 0.504 | |
3iw5 | DF3 | Mitogen-activated protein kinase 14 | / | 0.503 | |
2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.502 | |
1ie8 | KH1 | Vitamin D3 receptor | / | 0.501 | |
3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.501 | |
2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.500 | |
3zk5 | Z18 | Cytochrome P450 monooxygenase PikC | / | 0.499 | |
4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.499 | |
4loo | SB4 | Mitogen-activated protein kinase 14 | / | 0.499 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.498 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.497 | |
4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.497 | |
4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.494 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.493 | |
3l8x | N4D | Mitogen-activated protein kinase 14 | / | 0.493 | |
3uvp | 048 | Mitogen-activated protein kinase 14 | / | 0.493 | |
1ie4 | T44 | Transthyretin | / | 0.492 | |
2ca0 | PXI | Cytochrome P450 monooxygenase PikC | / | 0.492 | |
4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.492 | |
3flq | 891 | Mitogen-activated protein kinase 14 | / | 0.491 | |
4aa5 | NQB | Mitogen-activated protein kinase 14 | / | 0.491 | |
4xhg | ADP | Uncharacterized protein | / | 0.491 | |
1jio | DEB | 6-deoxyerythronolide B hydroxylase | / | 0.490 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.490 | |
2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.489 | |
2rg6 | 287 | Mitogen-activated protein kinase 14 | / | 0.489 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.489 | |
4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.489 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.488 | |
2gfs | PQB | Mitogen-activated protein kinase 14 | / | 0.488 | |
1di9 | MSQ | Mitogen-activated protein kinase 14 | / | 0.487 | |
3rin | I2O | Mitogen-activated protein kinase 14 | / | 0.487 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.487 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.486 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
3obg | SB2 | Mitogen-activated protein kinase 14 | / | 0.484 | |
3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.484 | |
3wmx | NAD | NAD dependent epimerase/dehydratase | / | 0.484 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.484 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.484 | |
4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.484 | |
3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.483 | |
3zcw | 4A2 | Kinesin-like protein KIF11 | / | 0.483 | |
2y03 | Y01 | Beta-1 adrenergic receptor | / | 0.482 | |
3a9w | NAD | NDP-sugar epimerase | / | 0.482 | |
3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.482 | |
4ezj | 0SC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.481 | |
4ryv | ZEA | Protein LlR18A | / | 0.481 | |
3fsf | FSS | Mitogen-activated protein kinase 14 | / | 0.480 | |
1t1r | IMB | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.479 | |
2c6h | PXI | Cytochrome P450 monooxygenase PikC | / | 0.479 | |
2ph5 | NAD | Homospermidine synthase | / | 0.479 | |
4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.479 | |
1w7h | 3IP | Mitogen-activated protein kinase 14 | / | 0.478 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.478 | |
3mpt | 1GK | Mitogen-activated protein kinase 14 | / | 0.478 | |
4dlj | 6RG | Mitogen-activated protein kinase 14 | / | 0.478 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.477 | |
2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.477 | |
2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.477 | |
3inx | JZC | Heat shock protein HSP 90-alpha | / | 0.477 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.477 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.477 | |
2bxe | 1FL | Serum albumin | / | 0.476 | |
3lfa | 1N1 | Mitogen-activated protein kinase 14 | / | 0.476 | |
3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.476 | |
4ia3 | BIV | Vitamin D3 receptor A | / | 0.476 | |
2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.475 | |
3a78 | 3EV | Vitamin D3 receptor | / | 0.475 | |
2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.474 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.474 | |
3bv3 | P39 | Mitogen-activated protein kinase 14 | / | 0.474 | |
3fmj | FMJ | Mitogen-activated protein kinase 14 | / | 0.474 | |
3u8w | 09J | Mitogen-activated protein kinase 14 | / | 0.474 | |
4b7s | QLE | Cytochrome P450 monooxygenase PikC | / | 0.474 | |
4nkv | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.474 | |
3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.473 | |
3tk3 | CPZ | Cytochrome P450 2B4 | 1.14.14.1 | 0.473 | |
4enh | FVX | Cholesterol 24-hydroxylase | / | 0.473 | |
4eny | J19 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.473 | |
4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.473 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.472 | |
1jip | KTN | 6-deoxyerythronolide B hydroxylase | / | 0.472 | |
1p44 | GEQ | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.472 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.472 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.472 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.472 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.472 | |
3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.472 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.471 | |
1m13 | HYF | Nuclear receptor subfamily 1 group I member 2 | / | 0.471 | |
2e9c | B75 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.471 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.471 | |
2vwp | NDP | Glucose 1-dehydrogenase | / | 0.471 | |
3p3z | P3Z | Putative cytochrome P450 | / | 0.471 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.471 | |
2eau | CZA | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.470 | |
4cd2 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.470 | |
4f9w | LM4 | Mitogen-activated protein kinase 14 | / | 0.470 | |
4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.470 | |
4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.470 | |
5itz | LOC | Tubulin beta-2B chain | / | 0.470 | |
1jvs | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.469 | |
1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.469 | |
1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.469 | |
2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.469 | |
2prh | 238 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.469 | |
2qa2 | FAD | Polyketide oxygenase CabE | / | 0.469 | |
2w7x | D1A | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.469 | |
3we4 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.469 | |
4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.469 | |
4jib | 1L6 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.469 | |
2dfd | NAD | Malate dehydrogenase, mitochondrial | 1.1.1.37 | 0.468 | |
2hcd | BIV | Vitamin D3 receptor A | / | 0.468 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.468 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.468 | |
2vzm | NRB | Cytochrome P450 monooxygenase PikC | / | 0.468 | |
3iqe | F42 | F420-dependent methylenetetrahydromethanopterin dehydrogenase | 1.5.98.1 | 0.468 | |
3vt5 | YI2 | Vitamin D3 receptor | / | 0.468 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.468 | |
4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.468 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.468 | |
4l3l | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.468 | |
4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.468 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.468 | |
2ww4 | ADP | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 2.7.1.148 | 0.467 | |
2yek | EAM | Bromodomain-containing protein 2 | / | 0.467 | |
2yfe | YFE | Peroxisome proliferator-activated receptor gamma | / | 0.467 | |
3d7t | STU | Tyrosine-protein kinase CSK | / | 0.467 | |
4d4s | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.467 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.467 | |
4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.467 | |
4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.467 | |
1fm4 | DXC | Major pollen allergen Bet v 1-L | / | 0.466 | |
1uu8 | BI1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.466 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.466 | |
2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.466 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.466 | |
3opd | HIE | Heat shock protein 83 | / | 0.466 | |
3rps | 4B0 | Casein kinase II subunit alpha | 2.7.11.1 | 0.466 | |
3ule | C69 | Actin-related protein 3 | / | 0.466 | |
3w5p | 4OA | Vitamin D3 receptor | / | 0.466 | |
4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.466 | |
4fjz | 4FJ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.466 | |
1tz8 | DES | Transthyretin | / | 0.465 | |
2g5c | NAD | Prephenate dehydrogenase | / | 0.465 | |
3h0a | D30 | Peroxisome proliferator-activated receptor gamma | / | 0.465 | |
3js2 | VM1 | Fibroblast growth factor receptor 1 | / | 0.465 | |
4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.465 | |
4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.465 | |
1i7i | AZ2 | Peroxisome proliferator-activated receptor gamma | / | 0.464 | |
1mb9 | ATP | Carboxyethyl-arginine beta-lactam-synthase | 6.3.3.4 | 0.464 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
2ycq | UPX | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.464 | |
3inm | NDP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.464 | |
3klj | FAD | NADH-rubredoxin oxidoreductase | 1.18.1.1 | 0.464 | |
3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.464 | |
3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.464 | |
3w2o | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.464 | |
4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.464 | |
4h50 | NAP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.464 | |
4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.464 | |
4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.464 | |
4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.464 | |
1d4a | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.463 | |
1yin | CM3 | Estrogen receptor | / | 0.463 | |
2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.463 | |
2hnz | PC0 | Gag-Pol polyprotein | 2.7.7.49 | 0.463 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.463 | |
2q9f | C3S | Cholesterol 24-hydroxylase | / | 0.463 | |
3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.463 | |
3t2k | FAD | Sulfide-quinone reductase | / | 0.463 | |
4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.463 | |
5br4 | NAD | Lactaldehyde reductase | 1.1.1.77 | 0.463 | |
1bl7 | SB4 | Mitogen-activated protein kinase 14 | / | 0.462 | |
1bve | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.462 | |
1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.462 | |
1pp9 | SMA | Cytochrome b | / | 0.462 | |
1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.462 | |
2duv | 371 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
2g78 | REA | Cellular retinoic acid-binding protein 2 | / | 0.462 | |
2iya | ZIO | Oleandomycin glycosyltransferase | / | 0.462 | |
3be9 | P04 | Casein kinase II subunit alpha | 2.7.11.1 | 0.462 | |
3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.462 | |
3n7u | NAD | Formate dehydrogenase, chloroplastic/mitochondrial | / | 0.462 | |
3pe6 | ZYH | Monoglyceride lipase | / | 0.462 | |
4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.462 | |
4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.462 | |
4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.462 | |
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.462 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.462 | |
4ite | TEY | Vitamin D3 receptor | / | 0.462 | |
4zca | ADP | Kinesin-like protein KIF11 | / | 0.462 | |
5eyp | LOC | Tubulin beta chain | / | 0.462 | |
1s9j | BBM | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.461 | |
2ath | 3EA | Peroxisome proliferator-activated receptor gamma | / | 0.461 | |
2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.461 | |
2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.461 | |
2rg5 | 279 | Mitogen-activated protein kinase 14 | / | 0.461 | |
3vt9 | YI4 | Vitamin D3 receptor | / | 0.461 | |
3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.461 | |
4ia7 | BIV | Vitamin D3 receptor A | / | 0.461 | |
4ly9 | 1YY | Glucokinase regulatory protein | / | 0.461 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.461 | |
4v12 | POG | MaoC like domain protein | / | 0.461 | |
2gek | GDP | Phosphatidyl-myo-inositol mannosyltransferase | 2.4.1.57 | 0.460 | |
2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
2rkv | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.460 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.460 | |
2w4i | VGA | Glutamate racemase | / | 0.460 | |
3cd5 | 7HI | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.460 | |
3f46 | I2C | 5,10-methenyltetrahydromethanopterin hydrogenase | 1.12.98.2 | 0.460 | |
3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.460 | |
3vt7 | VDX | Vitamin D3 receptor | / | 0.460 | |
4i4e | 1BQ | Focal adhesion kinase 1 | 2.7.10.2 | 0.460 | |
4kwi | 1TJ | Reductase homolog | / | 0.460 | |
4xe6 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
5jqb | IBP | Envelope glycoprotein | / | 0.460 | |
1err | RAL | Estrogen receptor | / | 0.459 | |
2vxo | XMP | GMP synthase [glutamine-hydrolyzing] | 6.3.5.2 | 0.459 | |
3ibd | CPZ | Cytochrome P450 2B6 | 1.14.13 | 0.459 | |
3qlr | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.459 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.459 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.459 | |
4xgx | ADP | FAD:protein FMN transferase | / | 0.459 | |
3rey | XAC | Adenosine receptor A2a | / | 0.459 | |
1dss | NAD | Glyceraldehyde-3-phosphate dehydrogenase | 1.2.1.12 | 0.458 | |
1lso | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.458 | |
1nyx | DRF | Peroxisome proliferator-activated receptor gamma | / | 0.458 | |
1pn3 | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.458 | |
1qzf | CB3 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.458 | |
1yw2 | PGJ | Mitogen-activated protein kinase 14 | / | 0.458 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.458 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.458 | |
3pt6 | SAH | DNA (cytosine-5)-methyltransferase 1 | 2.1.1.37 | 0.458 | |
3t2z | FAD | Sulfide-quinone reductase | / | 0.458 | |
3vrw | YS5 | Vitamin D3 receptor | / | 0.458 | |
3vtd | TKD | Vitamin D3 receptor | / | 0.458 | |
4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.458 | |
4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.458 | |
4iwy | ADP | Ribosomal protein S6--L-glutamate ligase | / | 0.458 | |
1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.457 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
1osv | CHC | Bile acid receptor | / | 0.457 | |
1sn0 | T44 | Transthyretin | / | 0.457 | |
1sn5 | T3 | Transthyretin | / | 0.457 | |
2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.457 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.457 | |
3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.457 | |
3v9v | 21L | Peroxisome proliferator-activated receptor gamma | / | 0.457 | |
3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.457 | |
4j03 | FVS | Bifunctional epoxide hydrolase 2 | 3.1.3.76 | 0.457 | |
1d7l | RFL | p-hydroxybenzoate hydroxylase | / | 0.456 | |
2agv | BHQ | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.456 | |
2iog | IOG | Estrogen receptor | / | 0.456 | |
2nq8 | ZID | Enoyl-ACP reductase | / | 0.456 | |
2qo4 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.456 | |
2uxu | NAR | HTH-type transcriptional regulator TtgR | / | 0.456 | |
2v9j | ATP | 5'-AMP-activated protein kinase subunit gamma-1 | / | 0.456 | |
3cgo | JNO | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.456 | |
3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.456 | |
3lu8 | IQX | Serum albumin | / | 0.456 | |
3njo | P2M | Abscisic acid receptor PYR1 | / | 0.456 | |
3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.456 | |
3s1c | ZIR | Cytokinin dehydrogenase 1 | 1.5.99.12 | 0.456 | |
3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.456 | |
4kzo | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.456 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
4n9w | GDP | Phosphatidyl-myo-inositol mannosyltransferase | 2.4.1.57 | 0.456 | |
4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.456 | |
4z61 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.456 | |
1bvg | DMP | Gag-Pol polyprotein | 3.4.23.16 | 0.455 | |
1uum | AFI | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.455 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.455 | |
2ds1 | 1CD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
2dwb | ANP | Aurora kinase A | 2.7.11.1 | 0.455 | |
2har | OCC | Vitamin D3 receptor | / | 0.455 | |
2kce | D16 | Thymidylate synthase | / | 0.455 | |
2pyw | ADP | Methylthioribose kinase | 2.7.1.100 | 0.455 | |
2qfx | NDP | Isocitrate dehydrogenase [NADP], mitochondrial | 1.1.1.42 | 0.455 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
3ada | NAD | Subunit alpha of sarocosine oxidase | / | 0.455 | |
3cgd | NAD | Coenzyme A disulfide reductase | / | 0.455 | |
3mvm | 39P | Mitogen-activated protein kinase 14 | / | 0.455 | |
3okx | SAM | S-adenosyl-L-methionine-binding protein RPA0152 | / | 0.455 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.455 | |
4a28 | ADP | Kinesin-like protein KIF11 | / | 0.455 | |
4ezl | 0SE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
4fhi | 0S4 | Vitamin D3 receptor A | / | 0.455 | |
4hw3 | 19G | Induced myeloid leukemia cell differentiation protein Mcl-1 | / | 0.455 | |
4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.455 | |
5cno | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
1iid | NHM | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.454 | |
1ml3 | NAD | Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 1.2.1.12 | 0.454 | |
1nvt | NAP | Shikimate dehydrogenase (NADP(+)) | / | 0.454 | |
1suo | CPZ | Cytochrome P450 2B4 | 1.14.14.1 | 0.454 | |
1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.454 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.454 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
2ydw | WSH | Bromodomain-containing protein 2 | / | 0.454 | |
3cv9 | VDX | Vitamin D3 dihydroxylase | / | 0.454 | |
3hng | 8ST | Vascular endothelial growth factor receptor 1 | 2.7.10.1 | 0.454 | |
3ix9 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
3mdm | FJZ | Cholesterol 24-hydroxylase | / | 0.454 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.454 | |
3sgt | P09 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | / | 0.454 | |
4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.454 | |
4ix6 | ADP | Uncharacterized protein | / | 0.454 | |
5k2a | ZMA | Adenosine receptor A2a | / | 0.454 | |
1ppj | SMA | Cytochrome b | / | 0.453 | |
1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
1ysx | 4EB | Serum albumin | / | 0.453 | |
2jko | BIJ | Focal adhesion kinase 1 | 2.7.10.2 | 0.453 | |
2q59 | 240 | Peroxisome proliferator-activated receptor gamma | / | 0.453 | |
2rc6 | NAP | Ferredoxin--NADP reductase | / | 0.453 | |
2x7g | PVB | SRSF protein kinase 2 | 2.7.11.1 | 0.453 | |
3dey | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.453 | |
3icr | COA | Coenzyme A disulfide reductase | / | 0.453 | |
3jsk | AHZ | Thiamine thiazole synthase | / | 0.453 | |
3jvh | HHV | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | / | 0.453 | |
3klm | DHT | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.453 | |
3p6o | ETG | Camphor 5-monooxygenase | 1.14.15.1 | 0.453 | |
3tqh | NDP | Quinone oxidoreductase | / | 0.453 | |
3w0a | DS5 | Vitamin D3 receptor | / | 0.453 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.453 | |
4be7 | ATP | Type I restriction enzyme EcoR124II R protein | 3.1.21.3 | 0.453 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.453 | |
4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
4gu6 | 10N | Focal adhesion kinase 1 | 2.7.10.2 | 0.453 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.453 | |
4ib4 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.453 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.453 | |
5upj | UIN | Gag-Pol polyprotein | / | 0.453 | |
4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.453 | |
1i8t | FAD | UDP-galactopyranose mutase | 5.4.99.9 | 0.452 | |
1knu | YPA | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
1lri | CLR | Beta-elicitin cryptogein | / | 0.452 | |
1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.452 | |
2cd8 | PXI | Cytochrome P450 monooxygenase PikC | / | 0.452 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.452 | |
2hw1 | ANP | Ketohexokinase | / | 0.452 | |
2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.452 | |
2qhm | 7CS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.452 | |
2y02 | Y01 | Beta-1 adrenergic receptor | / | 0.452 | |
3f47 | I2C | 5,10-methenyltetrahydromethanopterin hydrogenase | 1.12.98.2 | 0.452 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.452 | |
3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.452 | |
3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.452 | |
3m8q | DJZ | Gag-Pol polyprotein | 2.7.7.49 | 0.452 | |
3ort | AGS | Serine/threonine protein kinase | / | 0.452 | |
3tdl | 11D | Serum albumin | / | 0.452 | |
3vvp | BNU | Uncharacterized protein | / | 0.452 | |
3w0y | DS4 | Vitamin D3 receptor | / | 0.452 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
3zc3 | NAP | Ferredoxin--NADP reductase | 1.18.1.2 | 0.452 | |
4bzo | 676 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
4cql | NAD | Estradiol 17-beta-dehydrogenase 8 | 1.1.1.62 | 0.452 | |
4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.452 | |
4dca | ADP | Aminoglycoside phosphotransferase | / | 0.452 | |
4h3c | 0YZ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.452 | |
4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.452 | |
4jx1 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.452 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.452 | |
4nu5 | NAD | Phosphonate dehydrogenase | 1.20.1.1 | 0.452 | |
4xiw | AZM | Carbonic anhydrase, alpha type | / | 0.452 | |
1uu7 | BI2 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
2azz | TCH | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.451 | |
2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.451 | |
2i4z | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.451 | |
2pmo | HMD | Protein kinase 7 | / | 0.451 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.451 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.451 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.451 | |
2zba | ZBA | Trichothecene 3-O-acetyltransferase | / | 0.451 | |
3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
3fwj | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.451 | |
3jw3 | TOP | Dihydrofolate reductase | / | 0.451 | |
3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.451 | |
4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
4g21 | 0VP | Vitamin D3 receptor A | / | 0.451 | |
4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.451 | |
4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.451 | |
4l45 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.451 | |
4xiv | ACP | Chemotaxis protein CheA | 2.7.13.3 | 0.451 | |
1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
1hvy | D16 | Thymidylate synthase | 2.1.1.45 | 0.450 | |
1nzf | UPG | DNA beta-glucosyltransferase | / | 0.450 | |
1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.450 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.450 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.450 | |
1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
1vru | AAP | Gag-Pol polyprotein | 2.7.7.49 | 0.450 | |
2aib | ERG | Beta-elicitin cinnamomin | / | 0.450 | |
2cig | 1DG | Dihydrofolate reductase | 1.5.1.3 | 0.450 | |
2itx | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.450 | |
2nnh | REA | Cytochrome P450 2C8 | / | 0.450 | |
2vo0 | M03 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.450 | |
2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.450 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
3e5r | NAD | Glyceraldehyde-3-phosphate dehydrogenase 1, cytosolic | 1.2.1.12 | 0.450 | |
3eig | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.450 | |
3kpk | FAD | Sulfide-quinone reductase | / | 0.450 | |
3oc1 | BMU | Mitogen-activated protein kinase 14 | / | 0.450 | |
3oqu | A8S | Abscisic acid receptor PYL9 | / | 0.450 | |
3r1s | X73 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
3t2y | FAD | Sulfide-quinone reductase | / | 0.450 | |
3v04 | V04 | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.450 | |
3vsp | EK8 | Peroxisome proliferator-activated receptor gamma | / | 0.450 | |
4g1y | 0VO | Vitamin D3 receptor A | / | 0.450 | |
4icy | FAD | PgaE | / | 0.450 | |
4jrn | ANP | Rhoptry kinase family protein | / | 0.450 | |
4o2b | LOC | Tubulin beta-2B chain | / | 0.450 | |
4xf7 | ACP | Carbohydrate/pyrimidine kinase, PfkB family | / | 0.450 | |
5fkn | TDC | Tetracycline repressor protein class D | / | 0.450 | |
3uzc | T4E | Adenosine receptor A2a | / | 0.450 | |
1eup | ASD | 6-deoxyerythronolide B hydroxylase | / | 0.449 | |
1me8 | RVP | Inosine-5'-monophosphate dehydrogenase | / | 0.449 | |
1t87 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.449 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
2ibz | SMA | Cytochrome b | / | 0.449 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.449 | |
2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.449 | |
2o4r | VD5 | Vitamin D3 receptor | / | 0.449 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.449 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.449 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
2yix | YIX | Mitogen-activated protein kinase 14 | / | 0.449 | |
2zlc | VDX | Vitamin D3 receptor | / | 0.449 | |
3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.449 | |
3dl9 | V2H | Vitamin D 25-hydroxylase | / | 0.449 | |
3dxj | NE6 | DNA-directed RNA polymerase subunit beta | / | 0.449 | |
3dxj | NE6 | DNA-directed RNA polymerase subunit beta' | / | 0.449 | |
3gxo | MQA | Mitomycin biosynthesis 6-O-methyltransferase | / | 0.449 | |
3had | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.449 | |
3ibe | L64 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
3ids | NAD | Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 1.2.1.12 | 0.449 | |
3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.449 | |
3sa0 | NRA | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.449 | |
3tmz | 06X | Cytochrome P450 2B4 | 1.14.14.1 | 0.449 | |
3wy0 | COA | Uncharacterized protein | / | 0.449 | |
3zux | TCH | Transporter | / | 0.449 | |
4a9m | P9M | Bromodomain-containing protein 2 | / | 0.449 | |
4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.449 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.449 | |
4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
4fv7 | E94 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.449 | |
4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.449 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.449 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.449 | |
4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.449 | |
1j39 | UPG | DNA beta-glucosyltransferase | / | 0.448 | |
1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
1kyz | FER | Caffeic acid 3-O-methyltransferase | 2.1.1.68 | 0.448 | |
1qbg | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.448 | |
1rk3 | VDX | Vitamin D3 receptor | / | 0.448 | |
1s22 | ATP | Actin, alpha skeletal muscle | / | 0.448 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.448 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.448 | |
2ceo | T44 | Thyroxine-binding globulin | / | 0.448 | |
2w2l | NAD | D-mandelate dehydrogenase | / | 0.448 | |
2xcl | ANP | Phosphoribosylamine--glycine ligase | / | 0.448 | |
2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.448 | |
3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
3c4z | ADP | Rhodopsin kinase | / | 0.448 | |
3d8v | UD1 | Bifunctional protein GlmU | / | 0.448 | |
3hz1 | 37D | Heat shock protein HSP 90-alpha | / | 0.448 | |
3i81 | EBI | Insulin-like growth factor 1 receptor | 2.7.10.1 | 0.448 | |
3kpz | ZNE | Vitamin D3 receptor | / | 0.448 | |
3p99 | LNP | Lanosterol 14-alpha-demethylase | / | 0.448 | |
3ufn | ROC | Gag-Pol polyprotein | / | 0.448 | |
4elb | 34R | Dihydrofolate reductase | / | 0.448 | |
4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.448 | |
4fa6 | 0TA | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.448 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.448 | |
4i3v | NAD | Aldehyde dehydrogenase (NAD+) | / | 0.448 | |
4j4b | NAI | Uncharacterized protein | / | 0.448 | |
4l8u | 9AZ | Serum albumin | / | 0.448 | |
4lgh | 0JN | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.448 | |
4neu | Q1A | Receptor-interacting serine/threonine-protein kinase 1 | 2.7.11.1 | 0.448 | |
4nt0 | 3DU | Orotidine 5'-phosphate decarboxylase | 4.1.1.23 | 0.448 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.448 | |
4z07 | PCG | cGMP-dependent protein kinase 1 | 2.7.11.12 | 0.448 | |
3uza | T4G | Adenosine receptor A2a | / | 0.448 | |
1c6z | ROC | Protease | / | 0.447 | |
1khr | COA | Streptogramin A acetyltransferase | 2.3.1 | 0.447 | |
1q20 | PLO | Sulfotransferase family cytosolic 2B member 1 | 2.8.2.2 | 0.447 | |
1rby | KEU | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.447 | |
1uuo | BRF | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.447 | |
1zhz | ERG | Oxysterol-binding protein homolog 4 | / | 0.447 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.447 | |
2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.447 | |
2q6b | HR2 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.447 | |
2y00 | Y01 | Beta-1 adrenergic receptor | / | 0.447 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.447 | |
3bfa | 9OD | Odorant binding protein ASP1 | / | 0.447 | |
3cs8 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
3m7r | VDX | Vitamin D3 receptor | / | 0.447 | |
3p6m | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.447 | |
3u9e | COA | Lmo1369 protein | / | 0.447 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.447 | |
4bdb | ODO | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
4hee | 14R | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
4hys | 1BJ | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.447 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.447 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.447 | |
4lgg | VGG | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.447 | |
4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.447 | |
4otp | ADP | Serine/threonine-protein kinase RIO1 | 2.7.11.1 | 0.447 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.447 | |
1bmk | SB5 | Mitogen-activated protein kinase 14 | / | 0.446 | |
1dnp | FAD | Deoxyribodipyrimidine photo-lyase | 4.1.99.3 | 0.446 | |
1rf9 | DBR | Camphor 5-monooxygenase | 1.14.15.1 | 0.446 | |
2buj | STU | Serine/threonine-protein kinase 16 | / | 0.446 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
2itw | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.446 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.446 | |
2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
2vyn | NAD | Glyceraldehyde-3-phosphate dehydrogenase A | / | 0.446 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.446 | |
2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.446 | |
3ama | SKE | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.446 | |
3anl | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.446 | |
3cgf | JNF | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.446 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.446 | |
3mee | T27 | Gag-Pol polyprotein | 2.7.7.49 | 0.446 | |
3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.446 | |
3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.446 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
3stw | 2TD | Methylketone synthase I | / | 0.446 | |
4a1z | ADP | Kinesin-like protein KIF11 | / | 0.446 | |
4apu | A2K | Progesterone receptor | / | 0.446 | |
4d58 | BI9 | Focal adhesion kinase 1 | 2.7.10.2 | 0.446 | |
4eh3 | NAR | Mitogen-activated protein kinase 14 | / | 0.446 | |
4ez8 | DHF | Thymidylate synthase | 2.1.1.45 | 0.446 | |
4f9f | GDP | Putative glycosyltransferase | / | 0.446 | |
4iui | 1GQ | Estrogen receptor | / | 0.446 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.446 | |
4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.446 | |
4o0s | ADN | Aurora kinase A | 2.7.11.1 | 0.446 | |
4ubs | DIF | Pentalenic acid synthase | 1.14.15.11 | 0.446 | |
5c7o | NAD | Glyceraldehyde-3-phosphate dehydrogenase, testis-specific | 1.2.1.12 | 0.446 | |
5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.446 | |
1chw | HXC | Chalcone synthase 2 | 2.3.1.74 | 0.445 | |
1hpz | AAP | Gag-Pol polyprotein | 2.7.7.49 | 0.445 | |
1k6v | XN2 | Gag-Pol polyprotein | 3.4.23.16 | 0.445 | |
1kgj | FL8 | Transthyretin | / | 0.445 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.445 | |
1znq | NAD | Glyceraldehyde-3-phosphate dehydrogenase | 1.2.1.12 | 0.445 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.445 | |
2vwq | NAP | Glucose 1-dehydrogenase | / | 0.445 | |
2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.445 | |
3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.445 | |
3eej | 53R | Uncharacterized protein | / | 0.445 | |
3elj | GS7 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.445 | |
3g5s | FAD | Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO | / | 0.445 | |
3h6k | 33T | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.445 | |
3hdh | NAD | Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial | 1.1.1.35 | 0.445 | |
3kkv | B99 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.445 | |
3mnr | SD1 | Heat shock protein HSP 90-alpha | / | 0.445 | |
3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.445 | |
3qqk | X02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3r6s | CMP | CRP-like cAMP-activated global transcriptional regulator | / | 0.445 | |
3rm6 | 18Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3stv | 3HO | Methylketone synthase I | / | 0.445 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
3vt3 | VDX | Vitamin D3 receptor | / | 0.445 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
3w5r | LOA | Vitamin D3 receptor | / | 0.445 | |
3w5t | LHP | Vitamin D3 receptor | / | 0.445 | |
3zok | NAD | 3-dehydroquinate synthase, chloroplastic | 4.2.3.4 | 0.445 | |
3zsi | 52P | Mitogen-activated protein kinase 14 | / | 0.445 | |
4b7x | NAP | Probable oxidoreductase | / | 0.445 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.445 | |
4c9p | CAM | Cytochrome P450 | / | 0.445 | |
4cy8 | FDA | 2-hydroxybiphenyl-3-monooxygenase | / | 0.445 | |
4e5y | NDP | GDP-L-fucose synthase | 1.1.1.271 | 0.445 | |
4fhh | 0U3 | Vitamin D3 receptor A | / | 0.445 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
4g3r | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.445 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.445 | |
4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
4l44 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.445 | |
4okx | 198 | Androgen receptor | / | 0.445 | |
6upj | NIU | Gag-Pol polyprotein | / | 0.445 | |
1civ | NAP | Malate dehydrogenase [NADP], chloroplastic | 1.1.1.82 | 0.444 | |
1kzj | CB3 | Thymidylate synthase | / | 0.444 | |
1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
2b0m | 201 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.444 | |
2igo | FAD | Pyranose 2-oxidase | / | 0.444 | |
2jn3 | JN3 | Fatty acid-binding protein, liver | / | 0.444 | |
2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.444 | |
2zdt | 46C | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.444 | |
3c5u | P41 | Mitogen-activated protein kinase 14 | / | 0.444 | |
3gst | GPR | Glutathione S-transferase Mu 1 | 2.5.1.18 | 0.444 | |
3iw1 | ASD | Steroid C26-monooxygenase | 1.14.13.141 | 0.444 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
3kjs | DQ1 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.444 | |
3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
3oaf | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.444 | |
3p6p | A6B | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
3pp1 | IZG | Dual specificity mitogen-activated protein kinase kinase 1 | 2.7.12.2 | 0.444 | |
3r32 | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.444 | |
3ssn | MVI | Mycinamicin VI 2''-O-methyltransferase | / | 0.444 | |
3t9a | ANP | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 | / | 0.444 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.444 | |
3vso | EK1 | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
4aw3 | MYV | Mycinamicin IV hydroxylase/epoxidase | / | 0.444 | |
4cdm | FAD | Deoxyribodipyrimidine photolyase | / | 0.444 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.444 | |
4inb | 1F6 | Gag protein | / | 0.444 | |
4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.444 | |
4jx1 | CAH | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.444 | |
4lrz | ADP | PEP-dependent dihydroxyacetone kinase, ADP-binding subunit DhaL | 2.7 | 0.444 | |
4o2z | 046 | Mitogen-activated protein kinase | / | 0.444 | |
4xcv | NDP | Probable hydroxyacid dehydrogenase protein | / | 0.444 | |
4xwt | U5P | Ribonuclease J | / | 0.444 | |
5bt4 | 2LO | Bromodomain-containing protein 4 | / | 0.444 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.444 | |
4z35 | ON9 | Lysophosphatidic acid receptor 1 | / | 0.444 | |
1dkf | BMS | Retinoic acid receptor alpha | / | 0.443 | |
1jol | FFO | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
1q0q | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | 1.1.1.267 | 0.443 | |
1rkg | VD1 | Vitamin D3 receptor | / | 0.443 | |
1s6q | TPB | Gag-Pol polyprotein | 2.7.7.49 | 0.443 | |
1sqv | UHD | Cytochrome b | / | 0.443 | |
1t0l | NAP | Isocitrate dehydrogenase [NADP] cytoplasmic | 1.1.1.42 | 0.443 | |
1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.443 | |
2ham | C33 | Vitamin D3 receptor | / | 0.443 | |
2j4z | 626 | Aurora kinase A | 2.7.11.1 | 0.443 | |
2vtq | LZA | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2y8q | ADP | 5'-AMP-activated protein kinase subunit gamma-1 | / | 0.443 | |
2y9q | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
3a14 | NDP | 1-deoxy-D-xylulose 5-phosphate reductoisomerase | / | 0.443 | |
3d7k | D7K | Benzaldehyde lyase | / | 0.443 | |
3dho | B2M | Streptogramin A acetyltransferase | 2.3.1 | 0.443 | |
3ggg | NAD | Prephenate dehydrogenase | / | 0.443 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.443 | |
3irm | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.443 | |
3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.443 | |
4acm | 7YG | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
4bch | T7Z | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.443 | |
4bdf | H3R | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.443 | |
4ei7 | GDP | Plasmid replication protein RepX | / | 0.443 | |
4ejh | 0QA | Cytochrome P450 2A13 | 1.14.14.1 | 0.443 | |
4ful | 0VU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.443 | |
4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
4j54 | G52 | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.443 | |
4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.443 | |
4nxw | ADP | Mitochondrial dynamics protein MID51 | / | 0.443 | |
4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.443 | |
5aut | 2AN | Death-associated protein kinase 1 | 2.7.11.1 | 0.443 | |
5g3s | FDA | Flavin-dependent L-tryptophan oxidase VioA | / | 0.443 | |
1jut | LYD | Thymidylate synthase | / | 0.442 | |
1s0z | EB1 | Vitamin D3 receptor | / | 0.442 | |
1xqc | AEJ | Estrogen receptor | / | 0.442 | |
1yjq | NAP | 2-dehydropantoate 2-reductase | 1.1.1.169 | 0.442 | |
1yt9 | OIS | Gag-Pol polyprotein | / | 0.442 | |
1zys | 199 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
2bu8 | ADP | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 2.7.11.2 | 0.442 | |
2etr | Y27 | Rho-associated protein kinase 1 | 2.7.11.1 | 0.442 | |
2i4j | DRJ | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
2qo6 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.442 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.442 | |
2y01 | Y01 | Beta-1 adrenergic receptor | / | 0.442 | |
2y3s | TIR | TamL | / | 0.442 | |
2ydj | YDJ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
3b20 | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.442 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.442 | |
3gi5 | K62 | Gag-Pol polyprotein | / | 0.442 | |
3gw9 | VNI | Lanosterol 14-alpha-demethylase | / | 0.442 | |
3nc9 | TR3 | Ketohexokinase | / | 0.442 | |
3qfv | NM7 | Serine/threonine-protein kinase MRCK beta | 2.7.11.1 | 0.442 | |
3sp9 | IL2 | Peroxisome proliferator-activated receptor delta | / | 0.442 | |
3t54 | ATP | Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 | / | 0.442 | |
3uku | C69 | Actin-related protein 3 | / | 0.442 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.442 | |
3w0c | 6DS | Vitamin D3 receptor | / | 0.442 | |
4a2j | AS0 | Progesterone receptor | / | 0.442 | |
4at9 | UTP | Interleukin enhancer-binding factor 2 | / | 0.442 | |
4aw1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.442 | |
4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.442 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.442 | |
4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.442 | |
4g2h | 0VQ | Vitamin D3 receptor A | / | 0.442 | |
4h3y | SAH | tRNA (guanine-N(1)-)-methyltransferase | / | 0.442 | |
4jbp | YPH | Aurora kinase A | 2.7.11.1 | 0.442 | |
4q0a | 4OA | Vitamin D3 receptor A | / | 0.442 | |
4r20 | AER | Cytochrome P450 family 17 polypeptide 2 | / | 0.442 | |
4xuh | SFI | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.442 | |
1ci7 | CB3 | Thymidylate synthase | 2.1.1.45 | 0.441 | |
1db1 | VDX | Vitamin D3 receptor | / | 0.441 | |
1ee9 | NAD | Methylenetetrahydrofolate dehydrogenase [NAD(+)] | 1.5.1.15 | 0.441 | |
1g4s | TPS | Thiamine-phosphate synthase | / | 0.441 | |
1ia3 | TQ5 | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1l2j | ETC | Estrogen receptor beta | / | 0.441 | |
1nvr | STU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
1pdh | FAS | p-hydroxybenzoate hydroxylase | / | 0.441 | |
1rx8 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.441 | |
1v59 | FAD | Dihydrolipoyl dehydrogenase, mitochondrial | 1.8.1.4 | 0.441 | |
1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
1zeo | C01 | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
2brg | DFY | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
2has | C3O | Vitamin D3 receptor | / | 0.441 | |
2m56 | CAM | Camphor 5-monooxygenase | 1.14.15.1 | 0.441 | |
2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.441 | |
2wuf | KEM | 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase | 3.7.1.17 | 0.441 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.441 | |
3bgz | VX3 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
3c0i | 3AM | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.441 | |
3crl | ANP | [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 2.7.11.2 | 0.441 | |
3fco | IIG | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.441 | |
3fgo | CZA | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.441 | |
3ict | ADP | Coenzyme A disulfide reductase | / | 0.441 | |
3jqp | A2P | Ferredoxin--NADP reductase, apicoplast | / | 0.441 | |
3jwm | 5WB | Dihydrofolate reductase | / | 0.441 | |
3nwx | KVS | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
3q5k | D1U | Heat shock protein 83-1 | / | 0.441 | |
3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
3r3b | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.441 | |
3s79 | ASD | Aromatase | 1.14.14.14 | 0.441 | |
3stx | BKA | Methylketone synthase I | / | 0.441 | |
3v9y | 24L | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
3vru | YS3 | Vitamin D3 receptor | / | 0.441 | |
4a6c | QG9 | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
4a9h | TVP | Bromodomain-containing protein 2 | / | 0.441 | |
4bdd | Z0O | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
4hjf | C2E | GGDEF family protein | / | 0.441 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.441 | |
4lxh | C1E | Alpha/beta hydrolase fold | / | 0.441 | |
4nh8 | 2LC | Heat shock protein HSP 90-alpha | / | 0.441 | |
4q71 | FAD | Bifunctional protein PutA | / | 0.441 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
4rup | H97 | Vitamin D3 receptor A | / | 0.441 | |
1ao8 | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
1dhj | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
1drb | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
1mab | ATP | ATP synthase subunit alpha, mitochondrial | / | 0.440 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.440 | |
1rx7 | FOL | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
1zhw | HC2 | Oxysterol-binding protein homolog 4 | / | 0.440 | |
2agv | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.440 | |
2b5v | NAP | Glucose 1-dehydrogenase | / | 0.440 | |
2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.440 | |
2cy0 | NAP | Shikimate dehydrogenase (NADP(+)) | / | 0.440 | |
2czf | XMP | Orotidine 5'-phosphate decarboxylase | 4.1.1.23 | 0.440 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.440 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.440 | |
2uw0 | GVK | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.440 | |
2uzh | IPE | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | / | 0.440 | |
2vf0 | F89 | Thymidylate synthase | / | 0.440 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.440 | |
2zbz | VDX | Vitamin D3 dihydroxylase | / | 0.440 | |
3cge | NDP | Coenzyme A disulfide reductase | / | 0.440 | |
3cyx | ROC | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
3ept | FDA | Putative FAD-monooxygenase | / | 0.440 | |
3eql | MXP | DNA-directed RNA polymerase subunit beta | / | 0.440 | |
3eql | MXP | DNA-directed RNA polymerase subunit beta' | / | 0.440 | |
3fl8 | RAR | Dihydrofolate reductase | / | 0.440 | |
3fzp | AGS | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.440 | |
3gbk | 2PQ | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
3gcq | 1BU | Mitogen-activated protein kinase 14 | / | 0.440 | |
3h0s | B38 | Acetyl-CoA carboxylase | / | 0.440 | |
3i59 | N6R | CRP-like cAMP-activated global transcriptional regulator | / | 0.440 | |
3iup | NDP | Possible NADH oxidoreductase | / | 0.440 | |
3l08 | ZIG | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
3l0l | HC3 | Nuclear receptor ROR-gamma | / | 0.440 | |
3ml9 | ML9 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
3op5 | REB | Serine/threonine-protein kinase VRK1 | 2.7.11.1 | 0.440 | |
3r8p | Z46 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
3ua5 | 06X | Cytochrome P450 2B6 | 1.14.13 | 0.440 | |
3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.440 | |
3vt8 | YI3 | Vitamin D3 receptor | / | 0.440 | |
3w9r | A8S | Abscisic acid receptor PYL9 | / | 0.440 | |
3wgw | T2B | Proliferating cell nuclear antigen | / | 0.440 | |
4axd | ANP | Inositol-pentakisphosphate 2-kinase | 2.7.1.158 | 0.440 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.440 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.440 | |
4c8b | 0LI | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.440 | |
4e5n | NAD | Phosphonate dehydrogenase | 1.20.1.1 | 0.440 | |
4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
4h98 | 14Q | Uncharacterized protein | / | 0.440 | |
4i0t | 1B6 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.440 | |
4jap | COA | Alpha-pyrone synthesis polyketide synthase-like Pks11 | 2.3.1 | 0.440 | |
4jdr | FAD | Dihydrolipoyl dehydrogenase | 1.8.1.4 | 0.440 | |
4o70 | 1QK | Bromodomain-containing protein 4 | / | 0.440 | |
4uya | AGS | Mitogen-activated protein kinase kinase kinase 21 | 2.7.11.25 | 0.440 | |
5ijz | NAP | NADP-specific glutamate dehydrogenase | 1.4.1.4 | 0.440 |